Bhat V

Artificial Intelligence for Mental Health Program, St. Michael's Hospital, 193 Yonge Street 6-013, Toronto, ON, M5B 1M8, Canada. venkat.bhat@utoronto.ca.

17 papers · 1 preprint · ORCID

ArticlePsilocybin

Efficacy and Safety of Psychedelic Microdosing on Psychological Outcomes in Healthy Adults: A Systematic Review and Meta-analysis.

Meshkat S, Leung M, Meshkat S +13

Europe PMC2026
ArticleMDMA

Investigating the impact of serotonergic psychedelic drugs, MDMA and ketamine on social cognition in psychiatric disorders: A scoping review.

Smith SA, Mohammad H, Lee LHN +13

Europe PMC2026
ArticleKetamine

Ketamine and esketamine for the prevention of postpartum depression: A systematic review and network meta-analysis, with an integrated evidence synthesis.

Lunsky I, Gutierrez G, Wang X +8

Europe PMC2026
ArticlePsilocybin

Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical Implications.

Meshkat S, Jha MK, Bhat V

Europe PMC2026
ArticlePsychedelics

Magnitude of response in treatment and control groups within psychedelic trials for psychiatric disorders: A meta-analysis.

Meshkat S, Lin Q, Sousa-Ho R +15

Europe PMC2026
ArticlePsychedelics

Toward a definition of treatment-resistant posttraumatic stress disorder: A systematic review.

Al-Shamali HF, Meshkat S, Janssen-Aguilar R +12

Europe PMC2026
PreprintPsilocybin

Psychedelic Therapy, Positive Emotional Experiences, and the Central Role of Self-Compassion

Zeifman R, Danias G, Agin-Liebes G +6

Europe PMC2025
ArticleMDMA

Interventional Psychiatry and Emerging Treatments for Posttraumatic Stress Disorder (PTSD): A Systematic Review.

Janssen-Aguilar R, Meshkat S, Al-Shamali HF +14

Europe PMC2025
ArticlePsychedelics

Evolving Psychotherapeutic Approaches for PTSD: Beyond the Fear-Based Model.

Burback L, Winkler O, Jetly R +4

Europe PMC2025
ArticlePsilocybin

Therapeutic Effects of Low-Dose Psilocybin in Depression and Other Mental Disorders: A Systematic Review.

Meshkat S, Fang H, Sousa-Ho R +11

Europe PMC2026
ArticlePsilocybin

Efficacy and safety of psilocybin for the treatment of substance use disorders: A systematic review.

Meshkat S, Malik G, Zeifman RJ +12

Europe PMC2025
ArticlePsilocybin

Pharmacokinetics of Psilocybin: A Systematic Review.

Meshkat S, Al-Shamali H, Perivolaris A +13

Europe PMC2025
ArticlePsilocybin

Psychedelics and Suicide-Related Outcomes: A Systematic Review.

Meshkat S, Malik T, Zeifman R +13

Europe PMC2025
ArticlePsilocybin

Psilocybin-assisted massed cognitive processing therapy for chronic posttraumatic stress disorder: Protocol for an open-label pilot feasibility trial.

Meshkat S, J Zeifman R, Stewart K +5

Europe PMC2025
ArticlePsilocybin

Impact of psilocybin on cognitive function: A systematic review.

Meshkat S, Tello-Gerez TJ, Gholaminezhad F +11

Europe PMC2024
ArticleKetamine

Efficacy of ketamine for comorbid depression and acute or chronic pain: A systematic review.

Balachandran A, Tassone VK, Adamsahib F +5

Europe PMC2022
ArticleKetamine

Ketamine Assisted Psychotherapy: A Systematic Narrative Review of the Literature.

Drozdz SJ, Goel A, McGarr MW +6

Europe PMC2022
ArticlePsilocybin

Neuroimaging Correlates of Treatment Response with Psychedelics in Major Depressive Disorder: A Systematic Review.

Kuburi S, Di Passa AM, Tassone VK +7

Europe PMC2022